The GM pet industry continues apace–a California-based company has started taking orders for genetically modified cats, altered to ease the sufferings of humans who have pet allergies.
Allerca is selling the cats for $3,500 each, to be delivered starting in 2007. Up to 10 percent of the U.S. population has allergies to cats, and according to CNN, cat allergen is also one of the main causes of childhood allergies, asthma, and other respiratory diseases such as bronchitis. Allerca suppresses production of a protein secreted by the cat’s skin and salivary glands that cause cat allergies.
I expect little uproar about these cats, just as there was little long-lasting concern about GloFish, which have gone on sale in pet stores earlier this year–a zebra fish implanted with a fluorescent sea anemone gene. Americans have shown little to no compunction about accepting genetically modified food or genetically modified animals–why start now?
How AI is reinventing what computers are
Three key ways artificial intelligence is changing what it means to compute.
These weird virtual creatures evolve their bodies to solve problems
They show how intelligence and body plans are closely linked—and could unlock AI for robots.
A horrifying new AI app swaps women into porn videos with a click
Deepfake researchers have long feared the day this would arrive.
Surgeons have successfully tested a pig’s kidney in a human patient
The test, in a brain-dead patient, was very short but represents a milestone in the long quest to use animal organs in human transplants.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.